Bleeding Disorder

28 registered clinical trials studyying Bleeding Disorder — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study NCT05916469	Oregon Health and Science University	—
Recruiting	Early Genomic Testing for Inherited Bleeding Disorders NCT06736158	Queen's University	EARLY_Phase 1
Recruiting	Hormonal Management of Heavy Menstrual Bleeding in Adolescents NCT06740929	University Hospital, Geneva	—
Recruiting	Longitudinal Cohort of Thrombosis and Hemostasis Diseases NCT06727669	Peking University People's Hospital	—
Enrolling By Invitation	ATHNdataset Registry NCT06820515	American Thrombosis and Hemostasis Network	—
Recruiting	Recombinant vWF Concentrate and ECMO NCT06118372	University of Virginia	Phase 1
Recruiting	Hemophilia A Research Program NCT07414511	University of Washington	—
Recruiting	Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics NCT06635564	Medical University of Vienna	—
Withdrawn	Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidne NCT05790109	Brigham and Women's Hospital	N/A
Recruiting	Bleeding of Unknown Cause: a Swiss Case-control Study NCT05713734	University Hospital, Geneva	—
Recruiting	European Rare Blood Disorders Platform (ENROL) NCT06250595	Hospital Universitari Vall d'Hebron Research Institute	—
Completed	Extracorporeal Life Support and Modification of Hemostasis NCT04912336	University Hospital, Ghent	—
Completed	Protection of Knee Joints in Bleeding Disorder Patients NCT06039904	Ramathibodi Hospital	N/A
Recruiting	National Longitudinal Cohort of Hematological Diseases NCT04645199	Institute of Hematology & Blood Diseases Hospital, China	—
Completed	Examining the Experiences of Children With Blood Disorders NCT04600609	University of Texas Southwestern Medical Center	—
Recruiting	ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628	American Thrombosis and Hemostasis Network	—
Completed	Screening for Bleeding Disorders in Children NCT05214300	University Hospital, Montpellier	—
Completed	XIENCE 28 USA Study NCT03815175	Abbott Medical Devices	N/A
Completed	The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding NCT03871452	Haydarpasa Numune Training and Research Hospital	N/A
Completed	Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With NCT03834727	Oregon Health and Science University	—
Unknown	Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorde NCT04188171	Universidade do Porto	Phase 2 / Phase 3
Completed	Adjusted Fibrinogen Replacement Strategy NCT03444324	Biotest	Phase 3
Completed	XIENCE 28 Global Study NCT03355742	Abbott Medical Devices	N/A
Completed	Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds NCT04201860	Emiliano Petrucci	—
Completed	Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass NCT02979158	Umeå University	N/A
Completed	Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibili NCT02864875	University of Sao Paulo General Hospital	Phase 4
Completed	Role of Thromboelastography in Septic Shock NCT03095625	University of Turin, Italy	—
Completed	Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument NCT00772434	Rockefeller University	—